Claro Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Claro Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-462	Closed	-$35K	–	985
2018 Q4	$35K	Buy	+462	New	+$21K	0.03%	418

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Claro Advisors's ASXC Position: Q1 2019 in Review

Claro Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q1 2019, closing a stake of 462 shares — an estimated $35K sold.

Claro Advisors first reported a position in ASXC in Q4 2018 and held it in 1 quarter. The position peaked at $35K in Q4 2018. 149 funds tracked by Wall St. Rank hold ASXC as of Q1 2019.

Claro Advisors reported no remaining Asensus Surgical, Inc. position as of Q1 2019 after selling out during the quarter.
Claro Advisors sold 462 Asensus Surgical, Inc. shares in Q1 2019, an estimated $35K.
Claro Advisors first reported a position in Asensus Surgical, Inc. in Q4 2018 and held it in 1 quarter.
Claro Advisors's Asensus Surgical, Inc. position peaked at $35K in Q4 2018.
149 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.